Elmelech Idan bought BBOT
May 10, 2026 · Form 4 insider transaction
Elmelech Idan bought 758,222 shares of BridgeBio Oncology Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
758,222
Price
$0.00
Total value
N/A
InsiderElmelech Idan
RoleOfficer
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateMay 10, 2026
Filing dateMay 12, 2026
Shares owned after758,222
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
1/48th of the shares subject to such option vest and become exercisable in substantially equal monthly installments on each monthly anniversary of April 20, 2026, subject to the Reporting Person's continuous service to the Issuer on each such date.